Cancer false alarm may give false sense of security
the ONA take:
According to a new study published in the journal BMJ Open, Cancer Research UK researchers have found that having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
Researchers from the Health Behaviour Research Centre at University College London in United Kingdom conducted a review of 19 international studies to assess the effect of a cancer false alarm.
They found that patients may delay seeking help from a healthcare professional for new or recurrent symptoms if they feel that it is not cancer because of a previous false alarm or if they feel unsupported by the healthcare system.
Researchers found that if patients felt unsupported previously, there is a concern that the healthcare professional will think the patient is making a fuss out of nothing.
Results also showed that insufficient education at the time of the cancer false alarm made the patients feel like the doctor would not be able to help at the time of new onset of symptoms.
The findings suggest that patients should not have a false sense of security after experiencing a cancer false alarm, and that patients should still seek help from a healthcare professional if the experience new or recurrent symptoms.
Having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|